Soudi, A. Et Al. 2024. Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor.. Pharmaceuticals (Basel, Switzerland) , vol.17, no.5 .

Soudi, A., Bender, O., Celik, İ., El-Hafeez, A. A. A., Dogan, R., Atalay, A., ... Elkaeed, E. B.(2024). Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor.. Pharmaceuticals (Basel, Switzerland) , vol.17, no.5.

Soudi, Aya Et Al. "Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor.," Pharmaceuticals (Basel, Switzerland) , vol.17, no.5, 2024

Soudi, Aya Et Al. "Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor.." Pharmaceuticals (Basel, Switzerland) , vol.17, no.5, 2024

Soudi, A. Et Al. (2024) . "Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor.." Pharmaceuticals (Basel, Switzerland) , vol.17, no.5.

@article{article, author={Aya Soudi Et Al. }, title={Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor.}, journal={Pharmaceuticals (Basel, Switzerland)}, year=2024}